The Photodynamic Agent Designed by Involvement of Hydrogen Atom Transfer for Enhancing Photodynamic Therapy

Abstract

AbstractAlthough Type‐I photodynamic therapy has attracted increasingly growing interest due to its reduced dependence on oxygen, the design of effective Type‐I photosensitizers remains a challenge. In this work, we report a design strategy for Type‐I photosensitizers by the involvement of hydrogen atom transfer (HAT). As a proof of concept, a HAT‐involved Type‐I PS, which simultaneously generates superoxide and carbon‐centered radicals under light‐irradiation, was synthesized. This photosensitizer is comprised of a fluorene‐substituted BODIPY unit as an electron acceptor covalently linked with a triphenylamine moiety as an electron donor. Under light‐irradiation, photo‐induced intramolecular electron transfer occurs to generate the BODIPY anion radical and triphenylamine cation radical. The former transfers electrons to oxygen to generate O2−⋅, while the latter loses a proton to produce a benzyl carbon‐centered radical which is well characterized. The resulting carbon‐centered radicals efficiently oxidize NADH by HAT reaction. This photosensitizer demonstrates remarkable photocytotoxicity even under hypoxic conditions, along with outstanding in vivo antitumor efficacy in mouse models bearing HeLa tumors. This work offers a novel strategy for the design of Type‐I photosensitizers by involvement of HAT.